A Cured Coronavirus Disease 2019 Case of an 86-Year-Old With 13 Chronic Diseases: A Case Report [0.03%]
一例86岁合并13种慢性疾病的新冠肺炎治愈病例报告
Yanhong Tu,Ji Fang,Menghui Yin et al.
Yanhong Tu et al.
Pamela L Karas,Nicole M Rankin,Emily Stone
Pamela L Karas
Health professionals participating in multidisciplinary team (MDT) cancer meetings may not be aware of their medicolegal obligations. This commentary aims to identify medicolegal issues concerning multidisciplinary cancer care and provides ...
Acquired Resistance to Osimertinib Plus Savolitinib Is Mediated by MET-D1228 and MET-Y1230 Mutations in EGFR-Mutated MET-Amplified Lung Cancer [0.03%]
在EGFR突变型MET扩增肺癌中，获得性奥希替尼联合萨瓦利替尼抵抗由MET-D1228和MET-Y1230突变介导
Andrew J Piper-Vallillo,Brian T Halbert,Deepa Rangachari et al.
Andrew J Piper-Vallillo et al.
Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations [0.03%]
2019冠状病毒病在肺癌患者中的感染情况：发病率、临床表现及鉴别诊断考虑因素
Andrew J Piper-Vallillo,Meghan J Mooradian,Catherine B Meador et al.
Andrew J Piper-Vallillo et al.
Introduction: Lung cancer is associated with severe coronavirus disease 2019 (COVID-19) infections. Symptom overlap between COVID-19 and lung cancer may complicate diagnostic evaluation. We aimed to investigate the incide...
Patients With Lung Cancer and Coronavirus Disease 2019 Epidemic: An Experience From an Italian University Hospital [0.03%]
新型冠状病毒疫情下肺癌患者：意大利大学医院的经验
Giorgio Scagliotti,Silvia Novello,Andrea Veltri et al.
Giorgio Scagliotti et al.
Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People's Republic of China [0.03%]
新型冠状病毒肺炎疫情期间中国肺癌患者的实际情况
Rui Fu,Lin Wu,Chao Zhang et al.
Rui Fu et al.
Introduction: The coronavirus disease 2019 (COVID-19) outbreak throughout the world has affected millions of people in many ways, putting a huge burden on the health care system. The ongoing outbreak of this respiratory d...
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms [0.03%]
在EGFR突变的NSCLC患者中作为旁路耐药机制先后出现CCDC6-RET融合及BRAF V600E突变的个性化治疗
In this case report, we describe a case of sequential acquired CCDC6 -RET fusion and BRAF V600E mutation observed in a patient with EGFR-mutated NSCLC treated with osimertinib and with combined selpercatinib and osimertinib. The discovery o...